Showing results (11-20 of 120) with videos related to
Sort By:
Pageof 12
Otolaryngologia Polska = the Polish Otolaryngology|July 4, 2002
[Gene modified tumor vaccines in therapy of malignant melanoma]Piotr J Wysocki, Aldona Karczewska, Andrzej MackiewiczLife (Basel, Switzerland)|September 30, 2020
The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma PatientsKatarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, et al.International Journal of Cancer|April 12, 2002
Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancerEliza Kwiatkowska, Marek Teresiak, Danuta Breborowicz, et al.Acta Biochimica Polonica|September 30, 2003
Cancer immunotherapy using cells modified with cytokine genesDariusz W Kowalczyk, Piotr J Wysocki, Andrzej MackiewiczActa Biochimica Polonica|October 5, 2002
Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish populationKatarzyna Lamperska, Aldona Karezewska, Eliza Kwiatkowska, et al.Journal for Immunotherapy of Cancer|November 30, 2018
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsJacek Mackiewicz, Tomasz Burzykowski, Dariusz Iżycki, et al.Acta Biochimica Polonica|October 5, 2002
Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cellsPiotr Grabarczyk, Piotr J Wysocki, Katarzyna Gryska, et al.Oncotarget|February 14, 2018
Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironmentEwelina Dondajewska, Wojciech Juzwa, Andrzej Mackiewicz, et al.Acta Biochimica Polonica|March 14, 2007
The CDKN2a common variants: 148 Ala/Thr and 500 C/G in 3' UTR, and their association with clinical course of melanomaKatarzyna Monika Lamperska, Anna Przybyła, Witold Kycler, et al.Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
Targeted therapy of renal cell cancerPiotr J Wysocki, Jakob Zolnierek, Cezary Szczylik, et al.Pageof 12